Skip to Main Content
Contribute Try STAT+ Today

By the time Sanjeev Arora’s patient had trekked the 200 miles to his office to treat the illness destroying her liver, it was too late. What had kept her away before — a long waiting list and monthly travel for the intensive hepatitis C treatment she needed — was now no match for the deep belly pain that had begun to interfere with her day job. But the disease had progressed too far, and the woman passed away months later.

“I asked myself, ‘Why did she have to die when all the medications are available, the testing is available, and here I am with the knowledge to treat it?’” said Arora, a practicing internal physician at the University of New Mexico and the founder of a provider training program called Project ECHO that aims to equip rural caregivers with specialty expertise.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment